Roundup's Legal Battle Narrows: Supreme Court Snubs Key Cancer Claim, Impacting Thousands

The U.S. Supreme Court has dealt a significant blow to Bayer AG by refusing to hear its appeal regarding the Roundup weedkiller litigation. This pivotal decision preserves the ability of thousands of plaintiffs across the nation to continue their claims linking Roundup to cancer, a major setback for Bayer. The company had fervently hoped the appeal would allow it to use a federal preemption argument to dismiss state-level failure-to-warn claims, thereby resolving a substantial portion of the approximately 30,000 pending lawsuits. The high court's move did not rule on the scientific debate of Roundup's link to cancer but rather on this critical legal strategy, effectively shutting down a key pathway Bayer sought to limit its liabilities. This outcome deepens the legal and corporate challenges for Bayer, ensuring the protracted legal battle over Roundup continues for years to come.